Introduction: Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients. Methods: The Italian Society of Antimicrobial Therapy, Società Italiana di Terapia Antimicrobica (SITA), produced practical, hospital-wide recommendations on the management of Candida infection in non-immunocompromised patients in the hospital ward. Results and discussion: Our focus is on patient stratification in terms of risk factors for IC and of clinical severity, emphasising a high index of suspicion to ensure early diagnosis, early treatment and de-escalation when a patient is clinically stable, in order to optimise resource allocation. © 2013 Springer-Verlag.
Data di pubblicazione: | 2014 |
Titolo: | Error in An Italian consensus for invasive candidiasis management (ITALIC) |
Autore/i: | Scudeller, L; Viscoli, C.; Menichetti, F.; Del Bono, V.; Cristini, F.; Tascini, C.; Bassetti, M.; Viale, P.; Italic Group: Chiara, Adembri; Massimo, Antonelli; Giacomo, Borgonovo; Francesco, Bruno; Ercole, Concia; Francesco Giuseppe De, Rosa; Vincenzo, Emmi; Silvano, Esposito; Roberto, Fumagalli; Girardis, Massimo |
Autore/i UNIMORE: | |
Digital Object Identifier (DOI): | 10.1007/s15010-013-0577-x |
Rivista: | |
Volume: | 42 |
Fascicolo: | 2 |
Pagina iniziale: | 263 |
Pagina finale: | 279 |
Codice identificativo Scopus: | 2-s2.0-84898541587 |
Tipologia | Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
ITALIC proofs.pdf | Post-print | Open Access Visualizza/Apri | ||
Erratum2014.pdf | Versione editoriale | Open Access Visualizza/Apri |

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris